← All stocks

ATOSSA THERAPEUTICS, INC.

ATOS No buying or selling
CIK 0001488039 #4960 in the set updated 21 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

8 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
QUAY STEVEN C
President & CEO
88,038
$77.45K
Daniel Mark James
Chief Financial Officer
63,000
$55.42K
Finn Jonathan
Director
11,666
$10.26K
+600.2%
Remmel H. Lawrence
Director
10,683
$9.40K
Galli Stephen J
Director
10,006
$8.80K
+166,667%
Steinhart Richard I
Director
10,000
$8.80K
Chen Shu-Chih
Director
10,000
$8.80K
Cigler Tessa
Director
10,000
$8.80K

No percentages here. This company's share count has moved by a factor of 15.0 over the window, from 8,611,361 to 129,171,424 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 10
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 513,203
History held since 18 Apr 2017